Improvements in treating melanoma<\/h3>\n
![](\"https:\/\/www.cancer.net\/sites\/cancer.net\/files\/rru-tsai.png\")
<\/p>\n
Dr. Katy K. Tsai, the 2023 Cancer.Net Associate Editor for Melanoma & Skin Cancer<\/a>, discusses 2 studies in treating melanoma<\/a> with adjuvant therapies, which are drugs given after surgery to help reduce the risk of the cancer coming back. First, she discusses the phase 3 KEYNOTE-716 study<\/a>, which examined whether the immunotherapy drug pembrolizumab (Keytruda) could decrease the chance of the cancer returning and spreading to another part of the body in people with high-risk stage IIB or IIC melanoma. [2:40]<\/p>\n Next, she discusses the phase 2 KEYNOTE-942 trial<\/a>, which studied whether adding a personalized cancer vaccine<\/a> to pembrolizumab for people with high-risk stage III or IV melanoma could reduce the risk of the cancer returning and spreading to another part of the body compared to pembrolizumab alone. [5:06]<\/p>\n Dr. Manali I. Patel, the 2023 Cancer.Net Associate Editor for Health Equity<\/a>, discusses research exploring ways to improve health equity<\/a> in cancer care. The topics she discusses include:<\/p>\n A study<\/a> in which researchers explored how they could collect social determinants of health<\/a> information from the parents of children who were enrolled in clinical trials. [11:38]<\/p>\n<\/li>\n A study<\/a> that looked at whether an intervention program called PediCARE could help low-income families access social and economic resources, such as grocery and transportation resources, while their children received cancer care. [12:48]<\/p>\n<\/li>\n A study<\/a> that examined racial and ethnic disparities in end-of-life care<\/a> among people with gastrointestinal cancers<\/a>. [15:02]<\/p>\n<\/li>\n Results from the Sylvester Lung Screening Project<\/a>, which was a quality improvement program aimed at reducing disparities in lung cancer screening<\/a>. [16:02]<\/p>\n<\/li>\n A study<\/a> that researched whether a cross-border cancer treatment training and access program developed between the United States and Mexico could improve survival for children with acute lymphoblastic leukemia<\/a>. [17:13]<\/p>\n<\/li>\n A pair of studies on the financial hardships of having cancer, called financial toxicity<\/a>, including evaluating the relationship between high levels of medical debt and survival. [18:42]<\/p>\n<\/li>\n A brief overview of research around the importance of patient navigation. [19:59]<\/p>\n<\/li>\n<\/ul>\n Disclosure information for this podcast\u2019s speakers can be found in their individual biographies linked to above.<\/p>\n Was this podcast useful?<\/i><\/b> Please subscribe, rate, and review Cancer.Net Podcasts wherever you listen to podcasts. This prerecorded podcast can be listened to online or downloaded to your computer. A transcript<\/a> is also available. For more information, visit the <\/i>Cancer.Net podcast page<\/i><\/a>.<\/span><\/i><\/p>\n Cancer.Net podcasts are edited for length and content. <\/i><\/p>\nNew research addressing disparities in cancer care<\/h3>\n
![](\"https:\/\/www.cancer.net\/sites\/cancer.net\/files\/rru-manali-patel.png\")
<\/p>\n\n